Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 671

1.

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M.

Breast Cancer. 2019 Jun 5. doi: 10.1007/s12282-019-00984-1. [Epub ahead of print]

PMID:
31168692
2.

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Masuda N, Mukai H, Inoue K, Rai Y, Ohno S, Mori Y, Hashigaki S, Muramatsu Y, Umeyama Y, Iwata H, Toi M.

Breast Cancer. 2019 May 24. doi: 10.1007/s12282-019-00970-7. [Epub ahead of print] Erratum in: Breast Cancer. 2019 Jun 5;:.

PMID:
31127500
3.

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.

Im SA, Mukai H, Park IH, Masuda N, Shimizu C, Kim SB, Im YH, Ohtani S, Huang Bartlett C, Lu DR, Iyer S, Mori Y, Mori A, Gauthier E, Finn RS, Toi M.

J Glob Oncol. 2019 May;5:1-19. doi: 10.1200/JGO.18.00173.

4.

Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.

Ohno S, Mukai H, Narui K, Hozumi Y, Miyoshi Y, Yoshino H, Doihara H, Suto A, Tamura M, Morimoto T, Zaha H, Chishima T, Nishimura R, Ishikawa T, Uemura Y, Ohashi Y.

Breast Cancer Res Treat. 2019 May 21. doi: 10.1007/s10549-019-05276-y. [Epub ahead of print]

PMID:
31115845
5.

Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor.

Sakai K, Passioura T, Sato H, Ito K, Furuhashi H, Umitsu M, Takagi J, Kato Y, Mukai H, Warashina S, Zouda M, Watanabe Y, Yano S, Shibata M, Suga H, Matsumoto K.

Nat Chem Biol. 2019 Jun;15(6):598-606. doi: 10.1038/s41589-019-0285-7. Epub 2019 May 17.

PMID:
31101918
6.

Identification of Residues Critical for FPR2 Activation by the Cryptic Peptide Mitocryptide-2 Originating from the Mitochondrial DNA-Encoded Cytochrome b.

Lind S, Gabl M, Holdfeldt A, Mårtensson J, Sundqvist M, Nishino K, Dahlgren C, Mukai H, Forsman H.

J Immunol. 2019 May 1;202(9):2710-2719. doi: 10.4049/jimmunol.1900060. Epub 2019 Mar 22.

PMID:
30902901
7.

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.

Fujiwara Y, Mukai H, Saeki T, Ro J, Lin YC, Nagai SE, Lee KS, Watanabe J, Ohtani S, Kim SB, Kuroi K, Tsugawa K, Tokuda Y, Iwata H, Park YH, Yang Y, Nambu Y.

Br J Cancer. 2019 Mar;120(5):475-480. doi: 10.1038/s41416-019-0391-z. Epub 2019 Feb 12.

PMID:
30745582
8.

Low-tube-voltage CT assessment of Adamkiewicz artery: Precise comparison between 100-kVp- and 120-kVp protocols.

Kubota Y, Yokota H, Mukai H, Horikoshi T, Ota J, Okafuji Y, Ueda H, Matsumiya G, Uno T.

Eur J Radiol. 2019 Feb;111:56-61. doi: 10.1016/j.ejrad.2018.12.014. Epub 2018 Dec 14.

PMID:
30691665
9.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
10.

Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab.

Ren Q, Mohri K, Warashina S, Wada Y, Watanabe Y, Mukai H.

Mol Pharm. 2019 Mar 4;16(3):1065-1073. doi: 10.1021/acs.molpharmaceut.8b01052. Epub 2019 Jan 30.

PMID:
30633529
11.

Egg-Cracking Vibration as a Cue for Stink Bug Siblings to Synchronize Hatching.

Endo J, Takanashi T, Mukai H, Numata H.

Curr Biol. 2019 Jan 7;29(1):143-148.e2. doi: 10.1016/j.cub.2018.11.024. Epub 2018 Dec 27.

PMID:
30595517
12.

Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke.

Shimamura M, Nakagami H, Shimizu H, Mukai H, Watanabe R, Okuzono T, Kawano T, Ikeda Y, Hayashi H, Yoshida S, Ju N, Mochizuki H, Morishita R.

Sci Rep. 2018 Dec 11;8(1):17770. doi: 10.1038/s41598-018-35898-z.

13.

Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease.

Mukai H, Dai L, Chen Z, Lindholm B, Ripsweden J, Brismar TB, Heimbürger O, Barany P, Qureshi AR, Söderberg M, Bäck M, Stenvinkel P.

Nephrol Dial Transplant. 2018 Dec 7. doi: 10.1093/ndt/gfy352. [Epub ahead of print]

PMID:
30534995
14.

Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis.

Mukai H, Hatanaka K, Yagi N, Warashina S, Zouda M, Takahashi M, Narushima K, Yabuuchi H, Iwano J, Kuboyama T, Enokizono J, Wada Y, Watanabe Y.

J Control Release. 2019 Jan 28;294:185-194. doi: 10.1016/j.jconrel.2018.12.006. Epub 2018 Dec 7.

PMID:
30529725
15.

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.

Mukai H, Shimizu C, Masuda N, Ohtani S, Ohno S, Takahashi M, Yamamoto Y, Nishimura R, Sato N, Ohsumi S, Iwata H, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Lu DR, Toi M.

Int J Clin Oncol. 2019 Mar;24(3):274-287. doi: 10.1007/s10147-018-1353-9. Epub 2018 Dec 4.

16.

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.

Adams S, Loi S, Toppmeyer D, Cescon DW, De Laurentiis M, Nanda R, Winer EP, Mukai H, Tamura K, Armstrong A, Liu MC, Iwata H, Ryvo L, Wimberger P, Rugo HS, Tan AR, Jia L, Ding Y, Karantza V, Schmid P.

Ann Oncol. 2019 Mar 1;30(3):405-411. doi: 10.1093/annonc/mdy518.

PMID:
30475947
17.

[Pancreatic arteriovenous malformation perforated into the common bile and pancreatic ducts:a case report].

Urakami S, Miura S, Fujita K, Matsui S, Anami T, Watanabe A, Sugahara A, Mukai H, Yoshikawa T.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(11):1011-1017. doi: 10.11405/nisshoshi.115.1011. Japanese.

PMID:
30416153
18.

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.

Masuda N, Inoue K, Nakamura R, Rai Y, Mukai H, Ohno S, Hara F, Mori Y, Hashigaki S, Muramatsu Y, Nagasawa T, Umeyama Y, Huang X, Iwata H.

Int J Clin Oncol. 2019 Mar;24(3):262-273. doi: 10.1007/s10147-018-1359-3. Epub 2018 Nov 3.

19.

Perfluorocarbon-Based 19 F MRI Nanoprobes for In Vivo Multicolor Imaging.

Akazawa K, Sugihara F, Nakamura T, Matsushita H, Mukai H, Akimoto R, Minoshima M, Mizukami S, Kikuchi K.

Angew Chem Int Ed Engl. 2018 Dec 17;57(51):16742-16747. doi: 10.1002/anie.201810363. Epub 2018 Nov 27.

PMID:
30375721
20.

Traumatic axonal injury revealed by postmortem magnetic resonance imaging: A case report.

Makino Y, Arai N, Hoshioka Y, Yoshida M, Kojima M, Horikoshi T, Mukai H, Iwase H.

Leg Med (Tokyo). 2019 Feb;36:9-16. doi: 10.1016/j.legalmed.2018.09.019. Epub 2018 Oct 1.

PMID:
30312836
21.

Merging images with different central frequencies reduces banding artifacts in balanced steady-state free precession magnetic resonance cisternography.

Matsumoto K, Yokota H, Mukai H, Masuda Y, Uno T, Miyati T.

J Appl Clin Med Phys. 2018 Nov;19(6):234-243. doi: 10.1002/acm2.12468. Epub 2018 Oct 5.

22.

DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.

Ishihara H, Yamashita S, Fujii S, Tanabe K, Mukai H, Ushijima T.

Med Oncol. 2018 Sep 14;35(11):147. doi: 10.1007/s12032-018-1207-3.

PMID:
30218172
23.

Hormonal Therapy Resistant Estrogen-receptor Positive Metastatic Breast Cancer Cohort (HORSE-BC) Study : Current Status of Treatment Selection in Japan.

Iwamoto T, Taira N, Fujisawa T, Araki K, Sakamaki K, Sangai T, Kikawa Y, Shien T, Takao S, Sato M, Goto Y, Yoshida T, Takahashi M, Aihara T, Mukai H.

Acta Med Okayama. 2018 Aug;72(4):369-374. doi: 10.18926/AMO/56172.

24.

Expanding the Applicability of the Metal Labeling of Biomolecules by the RIKEN Click Reaction: A Case Study with Gallium-68 Positron Emission Tomography.

Nakamoto Y, Pradipta AR, Mukai H, Zouda M, Watanabe Y, Kurbangalieva A, Ahmadi P, Manabe Y, Fukase K, Tanaka K.

Chembiochem. 2018 Oct 4;19(19):2055-2060. doi: 10.1002/cbic.201800335. Epub 2018 Sep 14.

PMID:
30066425
25.

Advances in chemotherapy for HER2-negative metastatic breast cancer.

Mukai H, Ito M.

Chin Clin Oncol. 2018 Jun;7(3):26. doi: 10.21037/cco.2018.06.01. Review.

26.

[Clinical Practice of Carcinoma of Unknown Primary].

Hasegawa Y, Mukai H.

Gan To Kagaku Ryoho. 2018 Jun;45(6):891-893. Review. Japanese.

PMID:
30026408
27.

Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment.

Mukai H, Villafuerte H, Qureshi AR, Lindholm B, Stenvinkel P.

Semin Dial. 2018 Sep;31(5):435-439. doi: 10.1111/sdi.12731. Epub 2018 Jun 21.

PMID:
29926516
28.

Westermark sign and pulmonary embolus.

Shikino K, Mukai H, Ikusaka M.

QJM. 2018 Nov 1;111(11):829-830. doi: 10.1093/qjmed/hcy125. No abstract available.

PMID:
29893935
29.

Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry).

Ohashi Y, Ikeda M, Kunitoh H, Sasako M, Okusaka T, Mukai H, Fujiwara K, Nakamura M, Kimura T, Ibusuki K, Sakon M.

BMJ Open. 2018 May 30;8(5):e018910. doi: 10.1136/bmjopen-2017-018910.

30.

Cesium desorption behavior of weathered biotite in Fukushima considering the actual radioactive contamination level of soils.

Mukai H, Tamura K, Kikuchi R, Takahashi Y, Yaita T, Kogure T.

J Environ Radioact. 2018 Oct;190-191:81-88. doi: 10.1016/j.jenvrad.2018.05.006. Epub 2018 May 15.

PMID:
29775841
31.

Urokinase injection-triggered clearance enhancement of a 4-arm PEG-conjugated 64Cu-bombesin analog tetramer: A novel approach for the improvement of PET imaging contrast.

Matsumura K, Zouda M, Wada Y, Yamashita F, Hashida M, Watanabe Y, Mukai H.

Int J Pharm. 2018 Jul 10;545(1-2):206-214. doi: 10.1016/j.ijpharm.2018.05.014. Epub 2018 May 7.

PMID:
29746998
32.

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.

Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.

PLoS One. 2018 Apr 27;13(4):e0195585. doi: 10.1371/journal.pone.0195585. eCollection 2018.

33.

Gene Expression Profiling of the Intact Dermal Sheath Cup of Human Hair Follicles.

Niiyama S, Ishimatsu-Tsuji Y, Nakazawa Y, Yoshida Y, Soma T, Ideta R, Mukai H, Kishimoto J.

Acta Derm Venereol. 2018 Jul 11;98(7):694-698. doi: 10.2340/00015555-2949.

34.

Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease.

Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, Qureshi AR.

Kidney Blood Press Res. 2018;43(2):522-535. doi: 10.1159/000488699. Epub 2018 Mar 29.

35.

Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain.

Watanabe K, Hirano S, Kojima K, Nagashima K, Mukai H, Sato T, Takemoto M, Matsumoto K, Iimori T, Isose S, Omori S, Shibuya K, Sekiguchi Y, Beppu M, Amino H, Suichi T, Yokote K, Uno T, Kuwabara S, Misawa S.

J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1082-1087. doi: 10.1136/jnnp-2017-316601. Epub 2018 Apr 7.

PMID:
29627772
36.

Maternal hatching synchronization in a subsocial burrower bug mitigates the risk of future sibling cannibalism.

Mukai H, Hironaka M, Tojo S, Nomakuchi S.

Ecol Evol. 2018 Feb 22;8(6):3376-3381. doi: 10.1002/ece3.3894. eCollection 2018 Mar.

37.

Mitocryptides from Human Mitochondrial DNA-Encoded Proteins Activate Neutrophil Formyl Peptide Receptors: Receptor Preference and Signaling Properties.

Gabl M, Sundqvist M, Holdfeldt A, Lind S, Mårtensson J, Christenson K, Marutani T, Dahlgren C, Mukai H, Forsman H.

J Immunol. 2018 May 1;200(9):3269-3282. doi: 10.4049/jimmunol.1701719. Epub 2018 Mar 30.

38.

Stress-induced birefringence in the isotropic phases of lyotropic mixtures.

Fernandes PRG, Maki JN, Gonçalves LB, de Oliveira BF, Mukai H.

Phys Rev E. 2018 Feb;97(2-1):022705. doi: 10.1103/PhysRevE.97.022705.

PMID:
29548186
39.

Predictive value of genetic analysis for pathological complete response to preoperative treatment in HER2 positive, HR negative early breast cancer (PASSION trial).

Yamaguchi T, Mukai H, Takahashi M, Hara F, Yamauchi C, Yamashita S, Ushijima T.

Jpn J Clin Oncol. 2018 Apr 1;48(4):388-391. doi: 10.1093/jjco/hyy024.

PMID:
29506214
40.

Clinical significance of neutrophil gelatinase-associated lipocalin and galectin-7 in tape-stripped stratum corneum of acne vulgaris.

Watanabe K, Yoshino T, Takahashi M, Kondo S, Takahashi M, Matsukuma S, Mukai H, Fukuda H.

J Dermatol. 2018 May;45(5):618-621. doi: 10.1111/1346-8138.14261. Epub 2018 Feb 22.

PMID:
29473202
41.

Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors.

Yamada Y, Mukai H, Tokudome Y, Kaneko M, Kashiwabara K, Wada N.

Jpn J Clin Oncol. 2018 Mar 1;48(3):248-254. doi: 10.1093/jjco/hyy001.

PMID:
29385493
42.

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.

Mukai H, Svedberg O, Lindholm B, Dai L, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.

Nephrol Dial Transplant. 2019 Mar 1;34(3):442-448. doi: 10.1093/ndt/gfx371.

PMID:
29378035
43.

Potential usefulness of Brevibacillus for bacterial cancer therapy: intratumoral provision of tumor necrosis factor-α and anticancer effects.

Mukai H, Takahashi M, Watanabe Y.

Cancer Gene Ther. 2018 May;25(3-4):47-57. doi: 10.1038/s41417-017-0009-7. Epub 2017 Dec 18.

PMID:
29255215
44.

Increase in salivary oxytocin and decrease in salivary cortisol after listening to relaxing slow-tempo and exciting fast-tempo music.

Ooishi Y, Mukai H, Watanabe K, Kawato S, Kashino M.

PLoS One. 2017 Dec 6;12(12):e0189075. doi: 10.1371/journal.pone.0189075. eCollection 2017.

45.

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.

Dai L, Mukai H, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, Qureshi AR.

PLoS One. 2017 Dec 6;12(12):e0186659. doi: 10.1371/journal.pone.0186659. eCollection 2017.

46.

An Acquired Form of Dandy-Walker Malformation with Enveloping Hemosiderin Deposits.

Shiohama T, Ando R, Fujii K, Mukai H, Naruke Y, Sugita K, Kato E, Shimojo N.

Case Rep Pediatr. 2017;2017:3861608. doi: 10.1155/2017/3861608. Epub 2017 Oct 25.

47.

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial.

Shiroiwa T, Fukuda T, Shimozuma K, Mouri M, Hagiwara Y, Kawahara T, Ohsumi S, Hozumi Y, Sagara Y, Ohashi Y, Mukai H.

BMC Cancer. 2017 Nov 17;17(1):773. doi: 10.1186/s12885-017-3774-7.

48.

Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast Cancer.

Kawahara T, Shimozuma K, Shiroiwa T, Hagiwara Y, Uemura Y, Watanabe T, Taira N, Fukuda T, Ohashi Y, Mukai H.

Oncology. 2018;94(2):107-115. doi: 10.1159/000484142. Epub 2017 Nov 17.

49.

MR Imaging of the Superior Cervical Ganglion and Inferior Ganglion of the Vagus Nerve: Structures That Can Mimic Pathologic Retropharyngeal Lymph Nodes.

Yokota H, Mukai H, Hattori S, Yamada K, Anzai Y, Uno T.

AJNR Am J Neuroradiol. 2018 Jan;39(1):170-176. doi: 10.3174/ajnr.A5434. Epub 2017 Nov 9.

50.

Erratum to: Phase 1 study of darolutamide (ODM-201), a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer.

Matsubara N, Mukai H, Hosono A, Onomura M, Sasaki M, Yajima Y, Hashizume K, Yasuda M, Uemura M, Zurth C.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1073-1077. doi: 10.1007/s00280-017-3433-3. No abstract available.

PMID:
29063294

Supplemental Content

Support Center